Cambridge Investment Research Advisors’s Fisker Inc. FSR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-96,044
Closed -$168K 3420
2023
Q4
$168K Buy
96,044
+23,315
+32% +$82.5K ﹤0.01% 2948
2023
Q3
$467K Buy
72,729
+19,111
+36% +$116K ﹤0.01% 2135
2023
Q2
$302K Buy
53,618
+1,295
+2% +$7.47K ﹤0.01% 2519
2023
Q1
$321K Sell
52,323
-939
-2% -$6.47K ﹤0.01% 2431
2022
Q4
$387K Buy
53,262
+6,949
+15% +$51.7K ﹤0.01% 2233
2022
Q3
$350K Sell
46,313
-6,590
-12% -$59.4K ﹤0.01% 2242
2022
Q2
$453K Sell
52,903
-6,256
-11% -$64.8K ﹤0.01% 2031
2022
Q1
$763K Sell
59,159
-12,257
-17% -$154K ﹤0.01% 1782
2021
Q4
$1.12M Sell
71,416
-16,030
-18% -$277K 0.01% 1499
2021
Q3
$1.28M Buy
87,446
+19,267
+28% +$290K 0.01% 1356
2021
Q2
$1.31M Buy
68,179
+15,706
+30% +$232K 0.01% 1350
2021
Q1
$904K Sell
52,473
-17,974
-26% -$329K ﹤0.01% 1495
2020
Q4
$1.03M Buy
70,447
+28,768
+69% +$423K 0.01% 1286
2020
Q3
$601K Buy
+41,679
New +$569K ﹤0.01% 1489

Other funds holding FSR

Cambridge Investment Research Advisors's FSR Position: Q1 2024 in Review

Cambridge Investment Research Advisors sold out of Fisker Inc. (FSR) in Q1 2024, closing a stake of 96,044 shares — an estimated $168K sold.

Cambridge Investment Research Advisors first reported a position in FSR in Q3 2020 and held it in 14 quarters. The position peaked at $1.31M in Q2 2021. 52 funds tracked by Wall St. Rank hold FSR as of Q1 2024.

  • Cambridge Investment Research Advisors reported no remaining Fisker Inc. position as of Q1 2024 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 96,044 Fisker Inc. shares in Q1 2024, an estimated $168K.
  • Cambridge Investment Research Advisors first reported a position in Fisker Inc. in Q3 2020 and held it in 14 quarters.
  • Cambridge Investment Research Advisors's Fisker Inc. position peaked at $1.31M in Q2 2021.
  • 52 funds tracked by Wall St. Rank held Fisker Inc. as of Q1 2024.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2024, filed 24 Apr 2024.